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The aim of this study was to investigate and compare the effects of three herbal mixture
extracts on obesity induced by high-fat diet (HFD) in rats. The prescriptionsdPericarpium
citri reticulatae and Fructus crataegidwere used as matrix components and mixed with
Ampelopsis grossedentata, Salvia miltiorrhiza, and epigallocatechin-3-gallate (EGCG) to form
T1, T2, and T3 complexes, respectively. Results revealed that HFD feeding significantly
increased body weight gain, fat deposition, plasma lipid profiles, hepatic lipid accumula-
tion, and hepatic vacuoles formation, but decreased plasma levels of adiponectin in rats.
Only the T1 complex showed the tendency, although not significantly so, for decreased
HFD-induced body weight gain. T1 and T3 complexes significantly reduced HFD-induced
fat deposition, and plasma levels of triglyceride, total cholesterol, and low-density lipo-
protein cholesterol. Only the T1 complex significantly increased HFD-reduced adiponectin
levels in plasma, but decreased HFD-increased triglyceride content in liver tissues. All
complexes effectively inhibited HFD-induced vacuoles formation. The content of dihy-
dromyricetin, salvianolic acid B, and EGCG in T1, T2, and T3 complexes was 18.25 ± 0.07%,
22.20 ± 0.10%, and 18.86 ± 0.04%, respectively. In summary, we demonstrated that herbal
mixture extracts, especially T1 complex, exhibit antiobesity activity in HFD-fed rats.
Copyright © 2016, Food and Drug Administration, Taiwan. Published by Elsevier Taiwan
LLC. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Obesity, one of the global health problems, is characterized
by an increase in fat mass accumulation and body weight
gain [1]. Obesity is the main risk factor for metabolicical Co. Ltd., Number 20-
(C.-M. Yang), cmy@koda.
ministration, Taiwan. Publ
.org/licenses/by-nc-nd/4.0/syndrome, which is related to an increased risk of several
types of chronic diseases, including hyperlipidemia, hyper-
tension, atherosclerosis, fatty liver, insulin resistance, and
cancer [2]. The major strategy for prevention and treatment
of obesity is lifestyle modification, including dieting control
and physical exercise [3]. However, it is difficult to carry out1, Gongye 3rd Road, Pingzhen District, Taoyuan City 324, Taiwan.
com.tw (C.-H. Chen).
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sedentary lifestyle. Although several available antiobesity
drugs, including orlistat [4], rimonabant [5], and sibutramine
[6], have been approved as a therapeutic strategy to combat
obesity, the potential toxicity may limit their overall useful-
ness [7].
Herbal medicines can be defined as raw or extracted
products isolated from plants, and they are widely used for
prevention and treatment ofmany chronic diseases, including
obesity, because they have fewer side effects compared with
pharmacological drugs [8]. Pericarpium citri reticulatae, also
called Chenpi in Chinese, is the dried ripe fruit peel of Citrus
reticulata Blanco and its cultivars [9]. The methanol extracts of
Chenpi have been shown to inhibit adipogenesis in 3T3-L1
preadipocytes, suggesting that Chenpi may exhibit antiobe-
sity potential [10]. Fructus crataegi, also called as Shanzha in
Chinese and widely used as traditional medicine, is the ripe
fruit of Crataegus pinnatifida Bge. var. major N.E. Br. or C. pin-
natifida Bge. Shanzha has been demonstrated to exhibit
hypolipidemic activity and cholesterol lowering effects [11].
Ampelopsis grossedentata (Hand.-Mazz.) W. T.Wang, also called
Tengcha in Chinese, has been used as a daily drink and as folk
medicine for the treatment of hepatitis, hypertension, and
hyperglycemia [12]. Danshen (in Chinese), one of the tradi-
tional Chinese medicinal herbs, is the dried of root and
rhizome of Salvia miltiorrhiza Bunge and has been shown to
exhibit a variety of biological functions, including improving
microcirculation, suppressing the formation of thromboxane,
inhibiting platelet adhesion and aggregation, and protecting
against myocardial ischemia [13]. Epigallocatechin-3-gallate
(EGCG) is the most abundant catechin in green tea with
several potential health effects, including antiobesity and
weight maintenance properties [14].
Synergistic actions are of vital importance in traditional
Chinese medicines for prevention and treatment of chronic
diseases [15]. The possible explanations for the synergistic
actions of herbal medicines are that different herbal medi-
cines may mediate either the same or different targets in a
synergistic manner and may decrease the adverse effects or
increase pharmacological activity by herbaleherbal interac-
tion [16]. These specific functions of each component led us to
hypothesize that these components when used in combina-
tions could serve as an effective antiobesity prescription to
decrease body weight gain, remove excessive body fat accu-
mulation, and improve blood lipid profiles. The prescriptions
of herbal mixture extracts are Chenpi and Shanzha used as
matrix components and mixed with Tengcha, Danshen, and
EGCG to form T1, T2, and T3 complex, respectively. The pre-
sent study was carried out to investigate and compare the
antiobesity effects of three herbal mixture extracts in a rat
model fed with high-fat diet (HFD).2. Methods
2.1. Herbal mixture extracts preparation
The prescriptions of three herbal mixture extracts were
developed by Ko Da Pharmaceutical Co. Ltd. (Taoyuan,
Taiwan). The raw materials, including Chenpi, Shanzha,Danshen, and Tengcha, were obtained from Taiwan and
China herbal markets and identified in the Ko Da Pharma-
ceutical Co. Ltd. Research and Development Center (Taoyuan,
Taiwan), where voucher specimens have been kept. The EGCG
was purchased from Teavigo (DSM Nutritional Products Ltd.,
Heerlen, The Netherlands) with purity of 50% as claimed by
the supplier. The rawmaterials were extracted in boiled water
individually for two times (1 hour for each time) followed by
filtration. All filtrates were collected and subjected to vacuum
and reduced-pressure concentration to obtain extracts. The
dried powder of each extract was produced by freeze-drying.
Chenpi and Shanzha were used as matrix components and
mixed with Tengcha, Danshen, and EGCG to form T1, T2, and
T3 complex, respectively (Table 1). These three complexes
were used as commercial herbal supplements as an antiobe-
sity formula. The recommended daily allowance for the three
complexes in humans is 5 g/d. A formula is available for
converting the human equivalent dose to the animal dose in
mg/kg, i.e., multiply the human dose in mg/kg per day by 6.2
[17]. The dose of three complexes of ~500 mg/kg in rats was
obtained using the following equation:
83.3 mg/kg (5 g per 60 kg person)  6.2. (1)
2.2. Analysis of marker compounds content in three
herbal mixture extracts
Analytical high-performance liquid chromatography was
performed on Hitachi D-7000 Interface equipped with L-7100
pump, L-7455 detector, and L-7200 autosampler (Hitachi,
Tokyo, Japan) to determine the marker compounds in three
herbal mixture extracts. For the analysis of dihydromyricetin,
salvianolic acid B, and EGCG content in T1, T2, and T3 com-
plexes, respectively, the test solution was prepared by mixing
10mg of dried powderwith 10mL of 70% (v/v)methanol under
ultrasonic condition at room temperature for 1 hour followed
by filtration. These filtrates were filtrated through a 0.45-mm
filter and chromatographic separation was carried out on a
Mightysil RP-18 column (Kanto Chemical CO., INC., Tokyo,
Japan.) with the specification of 250 mm  4.6 mm, 5 mmusing
gradient solvent systems as summarized in Table 2. The UV
wavelength, flow rate and injection volume were set at
254 nm, 1.0 mL/min, and 10 mL, respectively. The standard
solution was prepared by mixing dihydromyricetin, salvia-
nolic acid B, or EGCG, respectively, with methanol to obtain
different concentrations through serial dilution.
2.3. Animals and experimental design
Wistar male rats (4 weeks old; 200e250 g) were purchased
from the National Laboratory Animal Center (Taipei, Taiwan).
This study protocol was approved by the Animal Research
Committee of Chung Yuan Christian University, Taoyuan,
Taiwan. Rats were housed two to a cage with controlled
temperature (25 ± 2C) and humidity (65 ± 5%) with 12-hour
light/dark cycles and maintained based on the guidelines
established by the Taiwan Government Guide for the Care and
Use of Laboratory Animals. After 1 week, rats were randomly
divided into five groups (n ¼ 10 for each group) as follows:
Table 1 e Compositions of three herbal mixture extracts.
Chinese name Common name Scientific name Part used Composition (%)
Matrix components Chenpi Tangerine peel Pericarpium citri reticulatae Dried ripe fruit peel 30
Shanzha Hawthorn fruit Fructus crataegi Dried ripe fruit 30
T1 Tengcha Ampelopsis grossedentata Dried stems and leaves 40
T2 Danshen Salvia root Salvia miltiorrhiza Dried roots and rhizome 40
T3 EGCG Epigallocatechin-3-gallate Dried leaves of green tea 40
EGCG ¼ epigallocatechin-3-gallate.
Table 2e Conditions of gradient solvent systems in HPLC analysis formarker compounds in three herbal mixture extracts.
Dihydromyricetin Salvianolic acid B EGCG
Time (min) ACN (%) 0.03% H3PO4 (%) Time (min) ACN (%) 1% Acetic acid (%) Time (min) ACN (%) 0.03% H3PO4 (%)
0 10 90 0 12 88 0 10 90
5 15 85 5 12 88 25 10 90
20 45 55 35 20 80 30 50 50
25 50 50 45 23 77 35 50 50
30 10 90 55 30 70 40 10 90
40 10 90 70 12 88 45 10 90
ACN ¼ acetonitrile; EGCG ¼ epigallocatechin-3-gallate; HPLC ¼ high-performance liquid chromatography.
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group; Group 3, HFD þ T1 group (orally received 500 mg/kg of
T1 complex daily for 8 weeks); Group 4, HFDþ T2 group (orally
received 500 mg/kg of T2 complex daily for 8 weeks); and
Group 5, HFD þ T3 group (orally received 500 mg/kg of T3
complex daily for 8 weeks). The compositions of normal diet
and HFD are summarized in Table 3. Rats were given the T1,
T2, and T3 complexes daily via oral tubing. At the end of the
experiments, rats were sacrificed with CO2 asphyxiation.
Blood samples were collected in a vacutainer tube containing
K3EDTA followed by centrifugation at 4000g for 10 minutes to
obtain plasma. The fat tissuesdincluding subcutaneous,
mesenteric, perirenal, and epididymal tissuesdwere isolated
and weighed.2.4. Analysis of biochemical parameters in plasma
2.4.1. Adiponectin levels
The levels of adiponectin in rat plasma were quantified using
quantitative sandwich enzyme immunoassay technique with
a specific monoclonal antibody against rat adiponectin that
has been precoated onto amicroplate. The optical density was
set to a wavelength of 450 nm according to themanufacturer's
instructions (R&D Systems, Inc., Minneapolis, MN, USA).
Plasma was diluted 1000-fold with commercial diluents prior
to the assay. Ten separate experiments were each tested in
duplicate.Table 3 e Compositions of normal diet and high-fat diet.
Compositions
Normal diet Casein (26%), corn starch (50%), sucrose (9%), corn
mineral mixture (4%), vitamin mixture (1%)
High-fat diet Casein (26%), corn starch (15%), sucrose (9%), beef t
(5%), mineral mixture (4%), vitamin mixture (1%)2.4.2. Levels of total cholesterol and triglyceride
The levels of total cholesterol (TC) and triglyceride (TG) in rat
plasma were determined using enzymatic colorimetric
method as described previously [18]. For TC measurement,
10 mL of plasma or cholesterol standard (200mg/dL) wasmixed
with a reaction buffer containing 0.3 mM 4-aminoantopyrine,
6 mM phenol, 0.5 U/mL peroxidase, 0.15 U/mL cholesterol
esterase, and 0.1 U/mL cholesterol oxidase. For TG measure-
ment, 10 mL of plasma or TG standard (200 mg/dL) was mixed
with a reaction buffer containing 0.5 mM 4-aminophenazone,
5.5 mM 4-chlorophenol, 1 mM ATP, 150 U/mL lipase, 0.4 U/mL
glycerol kinase, 1.5 U/mL glycerol-3-phosphate oxidase, and
0.5 U/mL peroxidase. The mixtures were allowed to react for
10 minutes at room temperature, and the optical density was
set to a wavelength of 500 nm. The plasma TC or TG level (mg/
dL) was calculated as follows:
(the absorbance of sample at 500 nm/the absorbance of
standard at 500 nm)  200. (2)
2.4.3. Levels of high-density lipoprotein cholesterol and low-
density lipoprotein cholesterol
The levels of high-density lipoprotein cholesterol (HDL-C) and
low-density lipoprotein cholesterol (LDL-C) in rat plasmawere
measured using the enzymatic colorimetric method as
described previously [19,20]. For HDL-C analysis, 200 mL ofCompany (location)
oil (5%), cellulose (5%), Oriental Yeast Co. Ltd. (Tokyo, Japan)
allow (40%), cellulose
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0.55 mM phosphotungstic acid and 25 mM magnesium chlo-
ride to precipitate the LDL and VLDL fractions. For LDL-C
analysis, 100 mL of plasma was mixed with separation buffer
containing 5000 IU/L heparin and 64 mM sodium citrate to
precipitate the HDL and VLDL fractions. The mixtures were
allowed to react for 10 minutes at room temperature and then
centrifuged at 10,000g for 15 minutes. Next, 100 mL of the su-
pernatant containing HDL-C and LDL-C or 10 mL of HDL-C and
LDL-C standard (200 mg/dL) was mixed with a reaction buffer
containing 0.3mM 4-aminoantipyrine, 6 mMphenol, 0.5 U/mL
peroxidase, 0.15 U/mL cholesterol esterase, and 0.1 U/mL
cholesterol oxidase. The mixtures were allowed to react for
10 minutes at room temperature, and the optical density was
set to a wavelength of 500 nm. The plasma HDL-C or LDL-C
level (mg/dL) was calculated as follows:
(absorbance of sample at 500 nm/absorbance of standard at
500 nm)  200. (3)
2.5. Preparation of liver homogenates
The liver samples (0.5 g) were homogenized in 10 mL of
chloroform and methanol (2:1, v/v) mixtures with a homoge-
nizer at 4C to obtain liver homogenate. The homogenates
were centrifuged at 10,000g for 1 hour at 4C. The supernatant
were collected and used for TC and TG analysis as described
above. The values of TC and TG content are expressed asmg/g
liver.
2.6. Histopathological analysis
Liver tissues were fixed in 10% formalin and embedded in
paraffin, then sectioned into 2-mm thickness using a micro-
tome. The paraffin-embedded tissues were dried at 60C for
1 hour and deparaffinized using a dip of xylene and gradient
concentration of ethanol. The microslide was stained with
hematoxylin and eosin stain and observed under a micro-
scope (BX51; Olympus, Tokyo, Japan).
2.7. Statistical analysis
Values are expressed as means ± standard deviation and
analyzed using one-way analysis of variance followed by
Fisher's protected Duncan's multiple range test for compari-
sons of group means, when the F value was significant
(p < 0.05). All statistical analyses were performed using SPSS
for Windows, version 10 (SPSS Inc., Chicago, IL, USA); a p
value < 0.05 was considered statistically significant.Figure 1 e Effects of three herbal mixture extracts on body
weigh changes in high-fat diet (HFD)-fed rat during the 8-
week experimental period. Rats were fed a normal diet (C),
HFD, or HFD with 500 mg/kg of T1, T2, and T3 complex for
8 weeks and the body weight was measured weekly.
Values from 10 rats are expressed as mean ± standard
deviation; means without a common letter differ
significantly (p < 0.05).3. Results and discussion
3.1. Effects of three herbal mixture extracts on body
weight in HFD-fed rats
Although the etiology of obesity is complex, the dietary factor,
especially the consumption of HFD, is regarded as one of the
major risk factors for obesity development [21]. In the presentstudy, we investigated and compared the effects of three
herbal mixture extracts on HFD-induced obesity in rats.
Herein, we found that HFD feeding effectively induced obesity
in rats, as evidenced by a significance increment of body
weight at the beginning of 4 weeks in comparison with the
control group (Figure 1). At the end of the experiment, the
average body weight of rats in the HFD group (496 ± 29 g) was
significantly higher than that in the control group (434 ± 34 g;
Table 4). Among these three herbal mixture extracts, only T1
complex supplementation showed a tendency, although not
at a significant level, toward reduction of body weight gain
caused by HFD, whereas T2 and T3 complexes did not exhibit
such effect (Table 4).3.2. Effects of three herbal mixture extracts on fat
deposition in HFD-fed rats
HFD feeding is critical for obesity development because excess
calorie intake can promote the development of a positive en-
ergy balance followed by increased visceral fat deposition
leading to abdominal obesity [22]. In this study, the weight of
viscera fat tissues was calculated as the sum of the weight of
mesenteric, perirenal, and epididymal fat tissues. The body fat
index is a ratio of the total fat tissues (viscera and subcu-
taneous) weight and body weight. Results revealed that HFD
feeding significantly increased fat deposition in comparison
with the control group, as evidenced by the increased viscera
(mesenteric þ perirenal þ epididymal) and subcutaneous fat
tissues weight (Table 4). T1 and T3 complex treatment
significantly decreased HFD-induced fat deposition, as
compared to the HFD group (Table 4). By calculation, therewas
an increase in the body fat index in HFD-fed rats in contrast to
decreased values from the groups of rats fed with T1 and T3
Table 4 e Effects of three herbal mixture extracts on body weight and fat tissue weight in high-fat diet fed rats.
C HFD HFD þ T1 HFD þ T2 HFD þ T3
Body weight (g) 434 ± 34a 496 ± 29bc 463 ± 35ac 501 ± 49b 486 ± 37bc
Mesenteric fat tissues (g) 6.0 ± 2.1a 11.2 ± 2.5b 9.4 ± 2.6c 12.0 ± 3.4b 9.5 ± 2.4c
Perirenal fat tissues (g) 7.0 ± 1.4a 20.2 ± 5.0b 15.5 ± 3.8c 19.9 ± 5.1bd 16.3 ± 4.0cd
Epididymal fat tissues (g) 6.3 ± 0.9a 15.8 ± 2.8b 12.7 ± 3.0c 15.8 ± 5.0b 12.1 ± 3.3c
Viscera fat tissues (g) 19.4 ± 4.0a 47.2 ± 8.9b 37.5 ± 8.9c 47.7 ± 12.6b 37.9 ± 9.1c
Subcutaneous fat tissues (g) 8.4 ± 3.2a 23.3 ± 10.0b 15.2 ± 4.3c 20.1 ± 7.0bc 16.5 ± 4.7c
Body fat index (%) 6.4 ± 1.4a 14.1 ± 2.8b 11.3 ± 2.3c 12.4 ± 3.5bc 11.2 ± 2.4c
Rats were fed a normal diet (C), a high-fat diet (HFD), or HFDwith 500 mg/kg of T1, T2, and T3 complex, respectively, for 8 weeks (n ¼ 10 for each
group). Values from 10 rats are expressed as mean ± standard deviation; means without a common letter in a row differ significantly (p < 0.05).
The weight of viscera fat tissues were calculated as the sum of the weight of mesenteric, perirenal, and epididymal fat tissues.
Body fat index is the ratio of the total fat tissues (viscera and subcutaneous) weight and body weight.
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body fat deposition in HFD-fed rats (Table 4).
3.3. Effects of herbal mixture extracts on plasma
adiponectin levels in HFD-fed rats
Adiponectin is an adipocyte-specific protein that mediates
manymetabolic processes such as glucose regulation and fatty
acid oxidation [23]. The plasma levels of adiponectin are
decreased inpatientswith obesity, type2diabetesmellitus, and
coronary artery disease and in rats with HFD-induced obesity
[24]. In addition, adiponectin knockout could accentuate HFD-
induced obesity in mice [25]. A similar finding was found in
this study,wherein theplasma levels of adiponectin inHFD-fed
rats were significantly lower than those of the control group
(Table 5). The T1 and T3 complex treatments effectively
increased HFD-reduced adiponectin levels in plasma to levels
approximating those in control rats (Table 5), whereas T2
complex did not exhibit such increased actions (Table 5).
3.4. Effects of three herbal mixture extracts on plasma
lipid profiles in HFD-fed rats
Obesity is deeply related to many chronic diseases,
including hyperlipidemia, hypertension, arteriosclerosis,
and cancer [26]. We showed that the plasma levels of TG,Table 5 e Effects of three herbal mixture extracts on adiponec
accumulation in liver tissue in high-fat diet (HFD)-fed rats.
C HFD
Adiponectin (mg/dL) 4.6 ± 0.8a 3.9 ± 0.3b
TG (mg/dL) 61 ± 12a 76 ± 13b
TC (mg/dL) 62 ± 7a 76 ± 13b
HDL-C (mg/dL) 14.4 ± 1.6a 15.7 ± 2.7a
LDL-C (mg/dL) 41 ± 7a 57 ± 11b
Weight (g) 10.8 ± 0.9a 12.7 ± 1.4b
TG (mg/g liver) 103 ± 11a 230 ± 57b
TC (mg/g liver) 49 ± 4a 57 ± 7b
HDL-C ¼ high-density lipoprotein cholesterol; LDL-C ¼ low-density lipop
Rats were fed a normal diet (C), HFD, or HFD with 500 mg/kg T1, T2, and T
expressed as mean ± standard deviation; means without a common letteTC, and LDL-C in HFD-fed rats were significantly higher
than those of control group (Table 5), indicating that HFD
feeding caused hyperlipidemia in rats. T1 and T3 complex
supplementation significantly decreased these changes
induced by HFD, whereas T2 complex did not exhibit such
ameliorative actions (Table 5). However, plasma HDL-C
levels were not significantly different among these five
groups (Table 5).3.5. Effects of three herbal mixture extracts on
hepatosteatosis in HFD-fed rats
HFD feeding has been shown to induce hepatosteatosis in
mice and in rats [27]. In this study, we found that HFD
feeding significantly increased liver weight (Table 5), hepatic
TG and TC accumulation (Table 5), and hepatic vacuoles
(Figure 2). Only T1 complex significantly decreased HFD-
increased liver weight and hepatic TG content (T2 and T3
complexes did not exhibit such actions; Table 5). However, all
treatments using these complexes did not affect HFD-
increased TC levels in liver tissues (Table 5). HFD-induced
hepatic vacuoles were suppressed by treatment using all
complexes in a similar extent to levels approximating those
in control rats (Figure 2).tin levels and lipid profiles in plasma as well as lipid
HFD þ T1 HFD þ T2 HFD þ T3
Plasma
4.7 ± 0.6a 4.1 ± 0.5ab 4.5 ± 0.8ab
57 ± 12a 64 ± 15ab 55 ± 11a
64 ± 9a 71 ± 10ab 60 ± 8a
14.8 ± 2.1a 15.0 ± 1.8a 14.5 ± 2.8a
43 ± 7a 50 ± 9ab 40 ± 7a
Liver
11.2 ± 1.2c 13.1 ± 1.7b 11.6 ± 1.7bc
164 ± 33c 209 ± 71b 176 ± 44bc
57 ± 4b 58 ± 8b 56 ± 9b
rotein cholesterol; TC ¼ total cholesterol; TG ¼ triglyceride.
3 complex for 8 weeks (n ¼ 10 for each group). Values from 10 rats are
r in a row differ significantly (p < 0.05).
Figure 2 e Effects of three herbal mixture extracts on hepatic vacuoles in high-fat diet (HFD)-fed rats at the end of
experiment. Rats were fed a normal diet (C), HFD, or HFD with 500 mg/kg of T1, T2, and T3 complex for 8 weeks.
Histopathological analysis of liver tissues by hematoxylin and eosin stain.
Table 6 e Comparison of three herbal mixture extracts on obesity-related parameters in HFD-fed rats.
T1 T2 T3 T1 T2 T3
Body weight þ   Plasma TG þþ  þþ
Viscera fat tissues þþ  þþ Plasma TC þþ  þþ
Subcutaneous fat tissues þþ  þþ Plasma LDL-C þþ  þþ
Body fat index þþ  þþ Liver weight þþ  þ
Adiponectin þþ  þ Liver TG þþ  þ
þþ ¼ significant effect; þ ¼ a tendency but not a significant effect;  ¼ no effect.
HFD ¼ high-fat diet; LDL-C ¼ low-density lipoprotein cholesterol; TG ¼ triglyceride.
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obesity-related parameters in HFD-fed rats
Among these three herbal mixture extracts, T1 complex
exhibited the highest antiobesity activity in HFD-fed rats as
summarized in Table 6. Interestingly, T2 complex did not
affect obesity-related parameters in HFD-fed rats (Table 6).We
ruled out that the matrix components, including Chenpi and
Shanzha, are involved in the modulation of obesity, although
Chenpi and Shanzha have been shown to exhibit antiobesity
potential [10] and hypolipidemic activity [11], respectively. We
considered that the active components, such as Tengcha in T1
complex and EGCG in T3 complex, may play an important role
in antiobesity activity in HFD-fed rats.
3.7. Marker compounds content in three herbal mixture
extracts
We speculated that dihydromyricetin, salvianolic acid B,
and EGCG can function as marker compounds with contents
of 18.25 ± 0.07% (Figures 3A and 3B), 22.20 ± 0.10% (Figures
3C and 3D), and 18.86 ± 0.04% (Figures 3E and 3F) in T1,
T2, and T3 complex, respectively. Dihydromyricetin, one of
the flavonoids, is the major bioactive component in Teng-
cha with several biological functions, including anti-
oxidation, anti-inflammation, hepatoprotective activity,and regulation of plasma lipids [28]. Similarly, our results
also revealed that the dihydromyricetin-rich T1 complex
exhibited hypolipidemic effects in HFD-fed rats (Table 5).
This study may provide a clue for dihydromyricetin, which
can be regarded as a novel compound for antiobesity
treatment.
Salvianolic acid B is a water-soluble compound in Danshen
with protective effects in the cardiocerebrovascular system
and therapeutic effects against HFD-induced obesity in mice
[29]. However, we found that the salvianolic acid B-rich T2
complex did not affect obesity-related parameters in HFD-fed
rats. EGCG, themost abundant catechin in green tea, has been
shown to have antiobesity activity [14]. Consistently, the
EGCG-rich T3 complex has the potential to reduce fat tissue
accumulation and improve abnormal plasma lipid profile in
HFD-fed rats.3.8. Conclusion
In this study, we demonstrated that herbal mixture extracts,
especially T1 complex (the mixtures of Chenpi, Shanzha, and
Tengcha), effectively improve HFD-induced obesity and hep-
atosteatosis in rats. Further studies are necessary to deter-
mine the exact synergistic effects of herbal mixture extracts
as an antiobesity and hepatoprotective agent.
Figure 3 e HPLC chromatogram of marker compounds in three herbal mixture extracts. (A) HPLC chromatogram of standard
dihydromyricetin (0.389 mg/mL). (B) HPLC chromatogram of dihydromyricetin in T1 complex. (C) HPLC chromatogram of
standard salvianolic acid B (0.4032 mg/mL). (D) HPLC chromatogram of salvianolic acid B in T2 complex. (E) HPLC
chromatogram of standard EGCG (0.2105 mg/mL). (F) HPLC chromatogram of EGCG in T3 complex. EGCG ¼ epigallocatechin-
3-gallate; HPLC ¼ high-performance liquid chromatography.
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